ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1584832

This article is part of the Research TopicNutraceuticals Modulation for Oxidative Stress in Disease and Health: Volume IIView all articles

Tamarix honey phenolics attenuate cisplatin-induced kidney toxicity by inhibition of inflammation mediated IL-6/STAT3/TNF-α and oxidative stress-dependent Nrf2/caspase-3 apoptotic signaling pathways

Provisionally accepted
  • 1King Saud University, Riyadh, Riyadh, Saudi Arabia
  • 2Nahda University, Beni Suef, Beni Suef, Egypt
  • 3nile valley university, Fayoum, Egypt
  • 4Faculty of Medicine, Beni-Suef University, Beni-Suef, Beni Suef, Egypt
  • 5Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Badr, Cairo, Egypt
  • 6Deraya Center for Scientific Research, Minia, Egypt
  • 7Institute for Organic Chemistry, Faculty of Chemistry and Pharmacy, Julius Maximilian University of Würzburg, Würzburg, Bavaria, Germany
  • 8Faculty of Pharmacy Beni-suef University, Beni Suef, Egypt
  • 9Faculty of Pharmacy, Sphinx University, Cairo, Beni Suef, Egypt

The final, formatted version of the article will be published soon.

Cisplatin (CIS) is a productive chemotherapeutic agent that is effective against a variety of cancer types. Its utilization is linked to acute kidney injury and other adverse consequences. Among its toxic effects are oxidative stress, apoptosis as well as inflammation. Saudi Tamarix honey (STH) is a valuable product with plentiful nutritional and health benefits, demonstrating advantageous effects against inflammation and oxidative stress. Therefore, this study examined the potential of STH to prevent oxidative stress, apoptosis, inflammation, and kidney impairment that are induced by CIS in rats, pointing to the entanglement of the Nrf2, the caspase-3, and the IL-6/STAT3/TNF-α signaling pathways. Histopathological examinations of the kidney were also used to evaluate cisplatin-induced nephrotoxicity. The rats received STH (50, 100 mg/kg) for 10 d and were challenged with a single dose of CIS (7 mg/kg) on day 7. CIS caused injury to the glomeruli and the tubules, increased lipid peroxidation, TNF-α, IL-6, cleaved caspase-3, and decreased cellular antioxidants in the kidneys of rats. STH effectively prevented tissue injury, and ameliorated oxidative stress, inflammatory markers, in addition to caspase-3 in CIS-administered rats. STH is rich with antioxidants, suppressed STAT3 protein expression, and upregulated Nrf2 in CIS-administered rats. In conclusion, STH mitigated CISinduced kidney injury by reducing oxidative stress, suppressing STAT3 and caspase-3, inhibiting pro-inflammatory mediators, and enhancing Nrf2 signaling. On the other hand, metabolomic profiling proposed the presence of 15 metabolites belonging to the chemical classes, phenolic acids, flavonoids and sterols, where phenolic acids were the most abundant classes.

Keywords: Cisplatin, nephrotoxicity, caspase-3, Nrf2, Oxidative Stress, STAT3 Cisplatin, stat3

Received: 27 Feb 2025; Accepted: 14 Apr 2025.

Copyright: © 2025 Aati, Aati, Bahr, Abdelsattar, Embaby, Reda, Abdelmohsen, Bringmann, Hassan and Darwish. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hossam M Hassan, Faculty of Pharmacy Beni-suef University, Beni Suef, Egypt

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.